Predicting a Patient’s Future with a Crystal Ball Comprised of Cell-free DNA
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
Biopharma Insights
Hunting Cancer Before It Can Hunt You: A Bird's Eye View of Cell-Free DNA Market Trends
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
Wielding New Cancer Weapons Forged in Cell-Free DNA: A Wake Up Call For The Entire Biotech Industry
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Life Sciences & Net Zero: Charting a Sustainable Path
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. …
MIT Unveils Breakthrough Technique for Noninvasive RNA Expression Studies
Researchers at the Massachusetts Institute of Technology (MIT) have made significant advancement in the study of cellular processes such as cancer …
Arguably, the World's First Real-time Pathogen Detection Device
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
9 Notable AI Companies in Clinical Research to Watch in 2023
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
AI Breaches the Barrier Towards Better CNS Drug Discovery
The sphere of oncology continues to grapple with the complex nature of brain and central nervous system (CNS) tumors. Data …
The Rising Popularity of Antibody-Drug Conjugates, with Challenges
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Addressing Inequity in Medical Research: The Need to Expand Genomic Databases
Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer …
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …